Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...
AstraZeneca Pharma India Limited has informed the Exchange regarding Notice of Postal Ballotmore...
Please find the enclosed Postal Ballot Notice dated February 11 2026 for your reference.more...
AstraZeneca Pharma India Limited has informed the Exchange about Copy of Newspaper Publicationmore...
AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Please find the enclosed certificate of the Company in relation to the captioned subject for your reference.more...
The company reported standalone net profit of Rs 32.59 crore for the quarter ended December 31 2025 as compared to Rs 30.85 crore in the sam...more...
AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11 2026.more...
Please find the enclosed financials of the Company for the quarter ended December 31 2025 for your reference.more...
Please find the enclosed letter of the Company as per the captioned subject for your reference.more...
AstraZeneca Pharma India Ltd on Tuesday said it has received regulatory approval from India s drug regulator to market its cancer therapy Imfinzi for...more...
Please find the enclosed intimation of the Company as per the captioned subject for your reference.more...
Organisation nod for Durvalumab in gastric cancer therapy AstraZeneca Pharma India Ltd has secured approval from the Central Drugs Standard ...more...
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.more...
Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia...more...
BOARD MEETINGS Company Name : Aadhaar Ventures Ind Date : 20-03-2026